ICR Discovery Club showcases how we take new drugs to cancer patients 22 Mar 2022 Members of the Discovery Club gathered at the Royal Society of Chemistry to hear how our scientists are moving new cancer drugs into the clinic. Find out more Show/Hide
Combination drug therapy can significantly benefit patients with newly diagnosed blood cancer 02 Aug 2021 A four-drug combination therapy that includes the novel drug carfilzomib can slow the progression of the blood cancer myeloma in patients who have been newly diagnosed with the disease, a phase III study has shown. Find out more Show/Hide
First Covid jab provides protection for most myeloma blood cancer patients 19 Apr 2021 A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus. Find out more Show/Hide